The innovative and personalized iLux® MGD Treatment System addresses Meibomian Gland Dysfunction (MGD), a leading cause of dry eye. Handheld and portable, the iLux® Device with Smart Tip Patient Interface enables ECPs to directly target a patient’s blocked Meibomian glands through the application of light-based heat and compression under direct visualization. The device expands the company’s current dry eye treatment offerings and allows practitioners to tailor treatment to the needs of each of their patients with dry eye disease in a matter of minutes.